Cardiovascular Diseases

Bedtime Antihypertensive Comparable to Morning Use

A Canadian study of adults with high blood pressure (BP) found no difference in health outcomes between taking BP medications in the morning versus at bedtime. A total of 3,357 adult patients with high BP (56.4% female; median age, 67 years; 53.7% on monotherapy) were randomly assigned to take their once-daily medication either in the morning or at night, and followed for a median of 4.6 years. Researchers found that the timing of medication did not impact the risk of death, hospitalization/emergency department visits for acute coronary syndrome, stroke, or heart failure, and there were no differences in falls, fractures, new glaucoma diagnoses, or cognitive decline between the two groups. A sister study similarly found that nursing home residents (median age 88 years) fared no better or worse if they starting taking their antihypertensives at bedtime. However, a substudy of ambulatory BP monitoring about 10 months into the trial found similar mean daytime BP unchanged with nighttime dosing but overnight mean BP significantly reduced by around -7.4/2.7 mm Hg. The findings suggest that taking BP medication at bedtime is safe but does not offer added benefits over morning use—so patients can choose whichever timing best fits their routine. Source: https://jamanetwork.com/

hyangiu

Recent Posts

ACS Updates Prostate Cancer Screening Guidance

The American Cancer Society (ACS) concludes that the benefits of PSA-based screening for prostate cancer…

22 hours ago

Proton Pump Inhibitor Use Linked to Dementia Risk in Older Adults

Proton pump inhibitor (PPI) use was modestly associated with incident dementia in older adults (pooled…

2 days ago

Long-Term Outcomes of Invasive vs Conservative Management in Stable Coronary Disease: Consistent Evidence From Extended Follow-Up Trials

Extended follow-up of three major trials consistently shows that an initial invasive strategy does not…

3 days ago

Antidepressants Differ in Efficacy and Acceptability in Long-Term Treatment of Major Depressive Disorder

Escitalopram, duloxetine, and agomelatine achieved higher sustained response rates than fluoxetine, while escitalopram and duloxetine…

3 days ago

Intensive BP Control Reduces Cardiovascular Events After Ischemic Stroke

Targeting a systolic blood pressure (BP) of less than 120 mm Hg lowered the incidence…

6 days ago

No Significant Reduction in Major Cardiovascular Events with Intensive BP Lowering in T2D

In patients with type 2 diabetes (T2D) and high cardiovascular risk, targeting a systolic blood…

6 days ago

This website uses cookies.